BECTON DICKINSON and CO

BD’s FY 2026 Q3 results webcast reveals how AI‑driven diagnostics, trade‑policy impacts and competitive pressures shape the company’s margins, market share and growth strategy.

BDX insider trade shows confidence in its value‑based diagnostics strategy—boosting patient outcomes while keeping costs down and attracting investors.

Insider trading at Becton, Dickinson (BDX) shows routine, plan‑based sales with no market impact, yet offers insight into RSU timing, governance, and digital health strategy.